Your session is about to expire
← Back to Search
Spread and Scale of a Polypharmacy App
N/A
Waitlist Available
Led By Emily McDonald, MD
Research Sponsored by Centre for Innovation and Research in Aging, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial tests MedReviewRx, an app that helps doctors and pharmacists review and simplify medications for older adults in New Brunswick nursing homes. The goal is to reduce unnecessary or harmful medications, making treatment safer and potentially lowering costs. The app analyzes medications and health conditions, providing reports to guide safer prescribing.
Eligible Conditions
- Overmedication
- Deprescribing
- Adverse Drug Reactions
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Impact of MedReviewRx on the prevalence of potentially inappropriate medications (PIMs) in New Brunswick nursing homes (NBNHs).
Secondary study objectives
Change in functional status based on interRAI activities of daily living (ADL) scores.
Number of changes from baseline in composite safety data
Number of deaths
+10 moreOther study objectives
Cost savings
Patient and family attitudes about deprescribing
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: MedReviewRxExperimental Treatment1 Intervention
During the intervention phase, MedReviewRx will be made available to nursing homes with the understanding that it will be used to facilitate medication reviews and prescription check-ups. MedReviewRx provides clinicians with access to individualized and prioritized deprescribing information from MedSafer which: a) identifies potentially inappropriate medications (PIMs), b) explains why the medication is potentially inappropriate and c) provides instructions on how to safely stop/taper the medication.
Group II: No MedReviewRxActive Control1 Intervention
During the control phase, MedReviewRx will not be accessible to health care professionals at the nursing homes. This serves to obtain baseline deprescribing levels for each nursing home.
Find a Location
Who is running the clinical trial?
McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER
470 Previous Clinical Trials
165,944 Total Patients Enrolled
Horizon Health NetworkOTHER
29 Previous Clinical Trials
15,815 Total Patients Enrolled
Missing Link TechnologiesUNKNOWN
New Brunswick Community CollegeUNKNOWN
Centre for Innovation and Research in Aging, CanadaLead Sponsor
1 Previous Clinical Trials
47 Total Patients Enrolled
Emily McDonald, MDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Carole Goodine, Pharm DPrincipal InvestigatorHorizon Health Network